Annual Cash & Cash Equivalents
$46.67 M
-$60.07 M-56.28%
31 December 2023
Summary:
Immunic annual cash & cash equivalents is currently $46.67 million, with the most recent change of -$60.07 million (-56.28%) on 31 December 2023. During the last 3 years, it has fallen by -$80.78 million (-63.38%). IMUX annual cash & cash equivalents is now -63.38% below its all-time high of $127.45 million, reached on 31 December 2020.IMUX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$59.07 M
-$20.63 M-25.88%
30 September 2024
Summary:
Immunic quarterly cash and cash equivalents is currently $59.07 million, with the most recent change of -$20.63 million (-25.88%) on 30 September 2024. Over the past year, it has dropped by -$618.00 thousand (-1.04%). IMUX quarterly cash and cash equivalents is now -55.65% below its all-time high of $133.18 million, reached on 30 September 2020.IMUX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMUX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.3% | -1.0% |
| 3 y3 years | -63.4% | -46.5% |
| 5 y5 years | +250.3% | +93.9% |
IMUX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.4% | at low | -46.5% | +26.6% |
| 5 y | 5 years | -63.4% | +250.3% | -55.6% | +218.0% |
| alltime | all time | -63.4% | +5712.4% | -55.6% | +1219.4% |
Immunic Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $59.07 M(-25.9%) |
| June 2024 | - | $79.70 M(-18.1%) |
| Mar 2024 | - | $97.31 M(+108.5%) |
| Dec 2023 | $46.67 M(-56.3%) | $46.67 M(-21.8%) |
| Sept 2023 | - | $59.69 M(-22.8%) |
| June 2023 | - | $77.29 M(-16.7%) |
| Mar 2023 | - | $92.76 M(-13.1%) |
| Dec 2022 | $106.75 M(+22.9%) | $106.75 M(+46.7%) |
| Sept 2022 | - | $72.77 M(-17.4%) |
| June 2022 | - | $88.08 M(-8.0%) |
| Mar 2022 | - | $95.71 M(+10.2%) |
| Dec 2021 | $86.86 M(-31.8%) | $86.86 M(-21.4%) |
| Sept 2021 | - | $110.44 M(+26.7%) |
| June 2021 | - | $87.17 M(-24.1%) |
| Mar 2021 | - | $114.84 M(-9.9%) |
| Dec 2020 | $127.45 M(+334.0%) | $127.45 M(-4.3%) |
| Sept 2020 | - | $133.18 M(+174.0%) |
| June 2020 | - | $48.61 M(+161.6%) |
| Mar 2020 | - | $18.58 M(-36.7%) |
| Dec 2019 | $29.37 M(+120.4%) | $29.37 M(-3.6%) |
| Sept 2019 | - | $30.46 M(-15.7%) |
| June 2019 | - | $36.12 M(+276.5%) |
| Mar 2019 | - | $9.60 M(-28.0%) |
| Dec 2018 | $13.32 M | $13.32 M(-25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $17.80 M(-42.8%) |
| June 2018 | - | $31.12 M(-28.7%) |
| Mar 2018 | - | $43.65 M(-23.3%) |
| Dec 2017 | $56.90 M(-5.2%) | $56.90 M(-14.3%) |
| Sept 2017 | - | $66.39 M(-12.8%) |
| June 2017 | - | $76.15 M(-12.1%) |
| Mar 2017 | - | $86.64 M(+44.4%) |
| Dec 2016 | $59.99 M(-28.1%) | $59.99 M(-11.9%) |
| Sept 2016 | - | $68.09 M(-7.5%) |
| June 2016 | - | $73.60 M(-5.5%) |
| Mar 2016 | - | $77.88 M(-6.6%) |
| Dec 2015 | $83.42 M(-18.4%) | $83.42 M(+39.6%) |
| Sept 2015 | - | $59.75 M(-16.9%) |
| June 2015 | - | $71.95 M(-18.5%) |
| Mar 2015 | - | $88.26 M(-13.7%) |
| Dec 2014 | $102.24 M(+167.7%) | $102.24 M(+29.3%) |
| Sept 2014 | - | $79.09 M(-12.9%) |
| June 2014 | - | $90.84 M(+97.3%) |
| Mar 2014 | - | $46.04 M(+20.6%) |
| Dec 2013 | $38.19 M(+752.9%) | $38.19 M(+22.6%) |
| Sept 2013 | - | $31.16 M(-14.5%) |
| June 2013 | - | $36.44 M(+713.9%) |
| Dec 2012 | $4.48 M(+457.5%) | $4.48 M |
| Dec 2011 | $803.00 K | - |
FAQ
- What is Immunic annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Immunic?
- What is Immunic annual cash & cash equivalents year-on-year change?
- What is Immunic quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Immunic?
- What is Immunic quarterly cash and cash equivalents year-on-year change?
What is Immunic annual cash & cash equivalents?
The current annual cash & cash equivalents of IMUX is $46.67 M
What is the all time high annual cash & cash equivalents for Immunic?
Immunic all-time high annual cash & cash equivalents is $127.45 M
What is Immunic annual cash & cash equivalents year-on-year change?
Over the past year, IMUX annual cash & cash equivalents has changed by -$60.07 M (-56.28%)
What is Immunic quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMUX is $59.07 M
What is the all time high quarterly cash and cash equivalents for Immunic?
Immunic all-time high quarterly cash and cash equivalents is $133.18 M
What is Immunic quarterly cash and cash equivalents year-on-year change?
Over the past year, IMUX quarterly cash and cash equivalents has changed by -$618.00 K (-1.04%)